SAFETY PROFILE OF LONG-TERM EXPOSURE TO RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS, ANALYSIS FROM A REAL-WORLD DATA NETWORK

EHA Library, Alberto Blanco Sánchez, 4160236

EFFICACY AND SAFETY OF FIRST-LINE IBRUTINIB PLUS VENETOCLAX IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) WHO WERE OLDER OR HAD TP53 MUTATIONS IN THE SYMPATICO STUDY

EHA Library, Gottfried von Keudell, 4160284

EVALUATION OF GONADAL FUNCTION IN FEMALE PATIENTS WITH HODGKIN LYMPHOMA (HL) AND PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL) UNDERGOING CHEMOTHERAPY

EHA Library, Angeliki Georgopoulou, 4160283

EVOLUTION OF TREATMENT PARADIGMS AND SURVIVAL OUTCOMES IN HODGKIN'S LYMPHOMA: A 20-YEARS' RETROSPECTIVE ANALYSIS OF 804 PATIENTS FROM A NATIONAL MEDICAL CENTER IN CHINA

EHA Library, Wenyan Yu, 4160282

SURVIVAL TRENDS IN HODGKIN LYMPHOMA (HL) FROM 1980 TO 2020: EXPERIENCE FROM A REFERRAL CENTER

EHA Library, Theodoros Vassilakopoulos, 4160281

ADULT LYMPHOMA-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CLINICAL FEATURES, DIAGNOSTIC CHALLENGES, AND TREATMENT OUTCOMES—A 24-YEAR SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Humberto Nieves-Jiménez, 4160280

REAL WORLD PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND OUTCOMES FOR CHINESE PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA

EHA Library, Kaiyang Ding, 4160279

RESPONSE ADAPTED THERAPY OF PEDIATRIC CLASSIC HODGKIN LYMPHOMA ACCORDING TO MODIFIED EURO-NET PROTOCOL-SINGLE CENTER EXPERIENCE

EHA Library, Hani Abdel Rahman Sayed, 4160278

CHARACTERISTICS AND PREDICTORS OF EARLY DEATHS IN CLASSICAL HODGKIN LYMPHOMA

EHA Library, Cong Sun, 4160277

CONSOLIDATION TREATMENT WITH BRENTUXIMAB VEDOTIN AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION FOR RELAPSED HODGKIN LYMPHOMA: ANALYSIS OF THE GHSG PHASE 2 BV-ALLO TRIAL

EHA Library, Christof Scheid, 4160276

PET-ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG-TERM FOLLOW-UP OF THE GATLA LH-05 TRIAL

EHA Library, Astrid Pavlovsky, 4160275

FIVE-YEAR EXPERIENCE WITH PD-1 INHIBITOR COMBINATION REGIMENS IN REFRACTORY CLASSIC HODGKIN LYMPHOMA AFTER FAILURE OF IMMUNE CHECKPOINT INHIBITOR MONOTHERAPY

EHA Library, Julia Zhuravleva, 4160274

PROGNOSTIC VALUE OF PET/CT BEFORE AUTOLOGOUS STEM-CELL TRANSPLANTATION IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA

EHA Library, Justin Ferdinandus, 4160273

TREATMENT EFFICACY FOR ADVANCED-STAGE CLASSIC HODGKIN LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

EHA Library, Rong Tao, 4160272

EVALUATION OF LONG-TERM OUTCOMES IN ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA TREATED WITH ABVD USING A PET-GUIDED STRATEGY

EHA Library, Jowon Laura Kim, 4160271

REAL-WORLD OUTCOMES OF PATIENT WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA TREATED WITH BRENTUXIMAB-VEDOTIN IN ASSOCIATION WITH BENDAMUSTINE: THE FRENCH LYSA EXPERIENCE

EHA Library, Gaétan Basile, 4160270

MYMPNVOICE APP: REMOTE LONGITUDINAL MONITORING OF PATIENT REPORTED OUTCOMES AND BIOMETRICS IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Patrick Harrington, 4160269

AN OPEN-LABEL CLINICAL TRIAL OF RVU120 AS MONOTHERAPY AND IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH INTERMEDIATE OR HIGH-RISK, PRIMARY OR SECONDARY MYELOFIBROSIS (POTAMI-61).

EHA Library, Rostislav Kuklík, 4160268

ASSESSMENT OF RISK FACTORS AND ANTICOAGULATION STRATEGY IN MYELOPROLIFERATIVE NEOPLASM-ASSOCIATED SPLANCHNIC VEIN THROMBOSIS (MPN-SVT): SINGLE-CENTRE, LONG-TERM, REAL-WORLD DATA.

EHA Library, Elena Torre, 4160267

CLINICAL PATHWAYS AND PROGNOSTIC STRATEGIES IN MYELOFIBROSIS: A REAL-WORLD ANALYSIS OF GERMAN PRACTICE

EHA Library, Francisco Henriquez, 4160266

RENAL FUNCTION MODERATES ASSOCIATIONS OF RED CELL MASS AND PLASMA VOLUME WITH THROMBOTIC RISK IN NEWLY DIAGNOSED POLYCYTHEMIA VERA PATIENTS

EHA Library, Danijela Lekovic, 4160265

FACTORS INFLUENCING CHR AND MR ACHIEVEMENT AND MAINTENANCE IN POLYCYTHEMIA VERA PATIENTS WITH HYDROXYUREA RESISTANCE/INTOLERANCE TREATED WITH ROPEGINTERFERON ALFA-2B

EHA Library, Sung-Eun Lee, 4160264

A PHASE 1B/2 STUDY OF DISC-0974, AN ANTI-HEMOJUVELIN ANTIBODY, IN PATIENTS WITH MYELOFIBROSIS AND ANEMIA

EHA Library, Sima Bhatt, 4160263

THE PROGNOSTIC IMPACT OF CYTOGENETIC AND MOLECULAR TESTING IN SECONDARY MYELOFIBROSIS

EHA Library, Holly Pertile, 4160262

A REAL-WORD STUDY ON THE EFFICACY AND SAFETY OF SELINEXOR PLUS RUXOLITINIB REGIMEN IN RUXOLITINIB-RESISTANT MYELOFIBROSIS

EHA Library, Na Xu, 4160261

GECACITINIB THERAPY'S IMPACT ON SYMPTOM BURDEN IN THE ZGJAK016 STUDY

EHA Library, Yi Zhang, 4160260

RESULTS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN ADVANCED MYELOFIBROSIS

EHA Library, Jong Hyuk Lee, 4160259

ARV-393, A PROTAC BCL6 DEGRADER, IS EFFICACIOUS IN PRECLINICAL MODELS OF DIFFUSE LARGE B CELL LYMPHOMA (DLBCL), NODAL T-FOLLICULAR HELPER CELL LYMPHOMA (NTFHL), AND TRANSFORMED FOLLICULAR LYMPHOMA (TFL)

EHA Library, Anna Van Acker, 4159412

CD4+ T CELL RECRUITMENT AND DIFFERENTIATION INTO A CYTOTOXIC PHENOTYPE IS ASSOCIATED WITH THE TREATMENT OF DLBCL PATIENTS WITH GLOFITAMAB TOGETHER WITH R-CHOP OR POLA-R-CHP

EHA Library, Thiago M Steiner, 4159413

PROGNOSTIC VALUE OF CIRCULATING TUMOR DNA (CTDNA) DETECTION BY PHASED-SEQ AFTER AXICABTAGENE CILOLEUCEL (AXI-CEL) THERAPY IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Brodie Miles, 4159414

COMBINATION WITH MOSUNETUZUMAB AND LENALIDOMIDE ENHANCES THE NUMBER OF CD8+ T CELLS WITH HIGH T CELL-DEPENDENT CELLULAR CYTOTOXIC ACTIVITY AGAINST FOLLICULAR LYMPHOMA CELLS

EHA Library, Hayato Mizuta, 4159415

FGF SIGNALING BLOCKADE HAMPERS THE GROWTH OF C-MYC-DRIVEN AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Jessica Faletti, 4159416

MAGNOLIN INHIBITS THE PROGRESSION OF DIFFUSE LARGE B-CELL LYMPHOMA BY ACTIVATING PPARG/PINK1-PARKIN AXIS AND PROMOTING MITOPHAGY

EHA Library, Shunfeng Hu, 4159417

CD19 EXPRESSION IS RETAINED IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA AFTER RECEIVING TAFASITAMAB, LENALIDOMIDE AND RITUXIMAB IN THE INMIND STUDY

EHA Library, Diana Alvarez Arias, 4159418

LONG-TERM SURVIVAL FOR LYMPHOID NEOPLASMS AND NATIONAL HEALTH EXPENDITURE (EUROCARE-6): A RETROSPECTIVE, POPULATION-BASED STUDY

EHA Library, Claudia Vener, 4159419

CHIDAMIDE ENHANCES CD7 CAR T-CELL EFFICACY IN T-CELL LYMPHOMA THROUGH EPIGENETIC CD7 UPREGULATION AND MITOCHONDRIAL APOPTOSIS PATHWAY ENGAGEMENT

EHA Library, Hao Yao, 4159420

IMMUNOGLOBULIN GENE REARRANGEMENTS AND CLONAL EVOLUTION AS PROGNOSTIC FACTORS IN B-NHL: A NOVEL APPROACH FOR MOLECULAR RISK STRATIFICATION

EHA Library, Xiao Liu, 4159422

MOLECULAR AND CELLULAR RESPONSES TO EXTERNAL TRIGGERING IN PRIMARY SPLENIC SMALL B-CELL LYMPHOMAS: A TRANSCRIPTOMIC AND BIOENERGETIC PERSPECTIVE

EHA Library, Marina Gerousi, 4159423

ROLE OF NON-CODING RNAS AND DNA METHYLATION IN REGULATING INTRACELLULAR SIGNALING AND CYTOKINE PATHWAYS IN MYD88WT WALDENSTRÖM MACROGLOBULINEMIA: A MULTI-OMICS EPIGENETIC ANALYSIS

EHA Library, Karan Chohan, 4159424

TARGETING ARGININE METHYLTRANSFERASE PRMT5 AS A PROMISING THERAPEUTIC STRATEGY IN NKTCL

EHA Library, Siyu Qian, 4159425

MYD88 MUTATIONS ARE ASSOCIATED WITH DISEASE PROGRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Issa Ismail Issa, 4159426

CIRCULAR RNAS, PROMISING THERAPEUTIC TARGETS IN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Loélia Babin, 4159427

THE RATIO OF BRAIN TO LIVER GLUCOSE ACTIVITY AND PROGNOSIS WITH CAR-T IN NON-HODGKIN LYMPHOMA

EHA Library, Sarah Dingli, 4159428

DEFERASIROX AS A NOVEL THERAPY TO OVERCOME MCL1-DRIVEN THERAPY ESCAPE IN MANTLE CELL LYMPHOMA

EHA Library, Saar Shapira, 4159429

DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): PROGNOSTIC IMPACT OF CD30 EXPRESSION AND ITS ASSOCIATION WITH THE TUMOR MICROENVIRONMENT

EHA Library, Ken Naganuma, 4159430

ROR1 SMALL MOLECULE INHIBITOR OVERCOMES IBRUTINIB AND VENETOCLAX RESISTANCE IN MANTLE CELL LYMPHOMA (MCL)

EHA Library, Wen Zhong, 4159431

IMMUNOGENETIC LANDSCAPE OF WALDENSTRÖM MACROGLOBULINEMIA: CORRELATION WITH CLINICO-BIOLOGICAL FEATURES, PROGNOSIS AND COMPARISON WITH PHYSIOLOGICAL MEMORY-B CELLS AND PLASMA CELLS

EHA Library, Clotilde Bravetti, 4159432

GENOMIC PROFILING IDENTIFIES UNIQUE MOLECULAR SUBGROUPS IN SPLENIC SMALL B-CELL LYMPHOMAS

EHA Library, Antonia-Zoe Kouroutzidou, 4159433

INVESTIGATING THE PATHOGENIC MECHANISMS OF ANGIOPATHY IN SYSTEMIC CHRONIC ACTIVE EPSTEIN-BARR VIRUS DISEASE USING ENDOTHELIAL CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS

EHA Library, Miwako Nishio, 4159434

SURVIVAL IMPACT AND KINETICS OF HEMOGLOBIN IMPROVEMENT WITH MOMELOTINIB IN PATIENTS WITH MYELOFIBROSIS AND MODERATE TO SEVERE ANEMIA: POST HOC ANALYSES OF SIMPLIFY-1 AND MOMENTUM

EHA Library, Francesca Palandri, 4160235

REAL-WORLD ZANUBRUTINIB TREATMENT PATTERNS IN MANTLE CELL LYMPHOMA AMONG US COMMUNITY ONCOLOGY PATIENTS WITH PRIOR BRUTON TYROSINE KINASE INHIBITOR THERAPY

EHA Library, Rushir Choksi, 4160320

IMPROVEMF UPDATE: PHASE 1/1B TRIAL OF IMETELSTAT (IME)+RUXOLITINIB (RUX) IN PATIENTS WITH INTERMEDIATE (INT)-1, INT-2, OR HIGH-RISK (HR) MYELOFIBROSIS (MF)

EHA Library, John Mascarenhas, 4160237

FIBROSIS GRADE BEFORE AND ITS RESOLUTION AFTER TRANSPLANTATION HAS NO PREDICTIVE VALUE IN MYELOFIBROSIS

EHA Library, Nico Gagelmann, 4160238

THE KEY ROLE OF MONOCYTES IN THE EVOLUTION OF MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Wayne-Corentin Lambert, 4160239

FINAL RESULTS OF A PILOT STUDY OF ELOTUZUMAB IN PATIENTS WITH MYELOFIBROSIS

EHA Library, Prithviraj Bose, 4160240

PROTECTIVE EFFECT OF ACETYLSALICYLIC ACID AND INTERFERON ALPHA ON LIVE BIRTH RATE IN MYELOPROLIFERATIVE NEOPLASMS: A META-ANALYSIS BASED ON THE SYSTEMATIC REVIEW OF 1,697 PREGNANCIES.

EHA Library, Monia Marchetti, 4160241

SURVIVAL OUTCOMES IN ACCELERATED AND BLAST PHASE MPN: A REAL-WORLD ANALYSIS FROM THE UK MPN CLINICAL STUDY GROUP.

EHA Library, Alexandros Rampotas, 4160242

DEFINING THE PROGNOSIS FOR ESSENTIAL THROMBOCYTHEMIA: A VALIDATION OF THE AAA+A RISK MODEL AND THE IDENTIFICATION OF A NEW PROGNOSTIC MARKER, THE LYMPHOCYTES-TO-MONOCYTES RATIO

EHA Library, Fabrizio Cavalca, 4160243

GECACITINIB IN JAKI-NAÏVE AND JAKI-EXPOSED MYELOFIBROSIS PATIENTS: IMPROVED TRANSFUSION INDEPENDENCE

EHA Library, Yi Zhang, 4160244

THROMBOSIS RISK AND HORMONE USE IN WOMEN WITH MPN : DATA FROM A CONTEMPORARY COHORT

EHA Library, Ikram-Nour Abda, 4160245

GENE EXPLORATION AND CLINICAL CHARACTERISTICS IN TRIPLE-NEGATIVE ESSENTIAL THROMBOCYTHEMIA VIA WHOLE EXOME SEQUENCING

EHA Library, Siraphop Thammayot, 4160246

IMPACT OF ELN CLINICAL SIGNS AND SYMPTOMS ON OUTCOMES IN POLYCYTHEMIA VERA PATIENTS TREATED WITH HYDROXYUREA OR RUXOLITINIB: A COOPERATIVE STUDY

EHA Library, Francesca Palandri, 4160247

IMPACTMF, RANDOMIZED, OPEN-LABEL, PHASE 3 TRIAL OF IMETELSTAT VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS RELAPSED OR REFRACTORY TO JANUS KINASE INHIBITORS

EHA Library, John Mascarenhas, 4160248

LYMPHOCYTE TO MONOCYTE RATIO MAY PREDICT TRANSFORMATION TO MYELOFIBROSIS FOR POLYCYTHEMIA VERA PATIENTS TREATED WITH RUXOLITINIB: EXPERIENCE FROM MAJIC-PV TRIAL

EHA Library, Andrea Duminuco, 4160249

PROGNOSTIC IMPLICATIONS OF RED BLOOD CELL DISTRIBUTION WIDTH-TO-ALBUMIN RATIO IN PATIENTS WITH MYELOFIBROSIS: INSIGHTS FROM A 10-YEAR RETROSPECTIVE AND MULTICENTER COHORT

EHA Library, Jian Huang, 4160250

A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL TO ADDRESS THE IMPACT OF TARGETED FLUDARABINE ON THE INCIDENCE OF VIRAL COMPLICATIONS AFTER αßTCR/CD19 DEPLETED ALLO-HCT

EHA Library, Moniek de Witte, 4160251

ALPHABETA T-CELL / CD19 GRAFT DEPLETED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN COMBINATION WITH POST-TRANSPLANT RUXOLITINIB FOR MYELOFIBROSIS

EHA Library, Anniek Stuut, 4160252

A NEW PROGNOSTIC RISK MODEL IN POLYCYTHEMIA VERA: THE TRIPLE A MODEL

EHA Library, Eda Nuhoğlu Kantarcı, 4160253

STUDY DESIGN AND DEMOGRAPHICS OF IMPRSSION, A PHASE 2 OPEN-LABEL CLINICAL TRIAL EVALUATING TMPRSS6 ANTISENSE INHIBITOR SAPABLURSEN, IN POLYCYTHEMIA VERA

EHA Library, Terrance Barrett, 4160254

SEX INFLUENCES MPN PHENOTYPE AND CLINICAL OUTCOMES: A REAL WORLD STUDY OF 1167 SUBJECTS FROM THE QUEBEC REGISTRY

EHA Library, Geneviève Huynh-Trudeau, 4160255

HEMATOLOGIC IMPROVEMENT EXPERIENCED BY PACRITINIB-TREATED PATIENTS WITH MYELOFIBROSIS IN REAL-WORLD CLINICAL SETTINGS

EHA Library, Michael Marrone, 4160256

GECACITINIB-INDUCED SPLEEN VOLUME REDUCTION (SVR) AND ITS PROGNOSTIC VALUE FOR OVERALL SURVIVAL (OS) IN MYELOFIBROSIS

EHA Library, Yi Zhang, 4160257

OPHTHALMOLOGICAL MANIFESTATIONS OF MYELOFIBROSIS AT THE ONSET AND DURING THERAPY

EHA Library, Olga Vinogradova, 4160258

VENOUS THROMBOEMBOLISM IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: INSIGHTS FROM REAL-WORLD DATA

EHA Library, Vladimir Otasevic, 4159396

TARGETED SUPPRESSION OF EFFECTOR T CELLS BY GPIBα CAAR-TREG CELLS IN REFRACTORY/RELAPSED IMMUNE THROMBOCYTOPENIA

EHA Library, Jinhui Shu, 4159395

G-CSF IMPROVES TREG SELECTION AND OUTCOMES OF HLA-HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION WITH T CELL ADOPTIVE IMMUNOTHERAPY

EHA Library, Rebecca Sembenico, 4159341

PHARMACOKINETIC-GUIDED ATG DOSING OPTIMIZES OUTCOMES IN MYELOABLATIVE HAPLO-CORD HCT

EHA Library, Qingya cui, 4159340

ANTI-CD25 ANTIBODY AS AN ALTERNATIVE TO METHOTREXATE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS RESULTED IN BETTER OUTCOMES IN PATIENT OF CHIMERIC ANTIGEN RECEPTOR-T CELL THERAPY BRIDGING TO TRANSPLANT

EHA Library, Zhihui Li, 4159339

AUTONOMOUS AI-DRIVEN INTENSIFIED PROPHYLAXIS OF SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE IN HAPLOIDENTICAL TRANSPLANTS: A SINGLE-CENTRE, PROOF-OF-CONCEPT, PHASE 2 TRIAL

EHA Library, Yigeng Cao, 4159338

POOLED FECAL ALLOGENIC MICROBIOTHERAPY FOR REFRACTORY GASTROINTESTINAL ACUTE GRAFT-VERSUS-HOST DISEASE : RESULTS FROM THE EARLY ACCESS PROGRAM IN EUROPE

EHA Library, Mohamad Mohty, 4159337

THE EVALUATION OF CIRCULATING TUMOR CELLS AS A PROGNOSTIC BIOMARKER IN NEWLY DIAGNOSED LIGHT CHAIN AMYLOIDOSIS

EHA Library, Ioannis Kostopoulos, 4159272

EFFICACY AND SAFETY OF CYCLOSPORINE PLUS LUSPATERCEPT VERSUS CYCLOSPORINE IN NEWLY DIAGNOSED NON-TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA: A PROSPECTIVE RANDOMIZED TRIAL

EHA Library, Zhuxin Zhang, 4159261

APPULSE-PNH: ORAL IPTACOPAN MONOTHERAPY DEMONSTRATES CLINICALLY MEANINGFUL HEMOGLOBIN (HB) INCREASES IN PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND HB ≥10 G/DL ON ANTI-C5 THERAPY

EHA Library, Austin G. Kulasekararaj, 4159260

HIGH PROPORTION OF PNH TYPE II NEUTROPHILS, I.E RELATIVE PERCENTAGE ≥3%, IS ASSOCIATED WITH THROMBOSIS IN PATIENTS DISPLAYING A PNH CLONE >1%: EVIDENCE FROM ANALYSIS OF THE 5-YEAR FRENCH NATION-WIDE MULTICENTER OBSERVATIONAL STUDY

EHA Library, Orianne Wagner-Ballon, 4159259

SLF2, A NOVEL CAUSATIVE GENE FOR INHERITED BONE MARROW FAILURE SYNDROMES AND MDS, AND ITS SIGNIFICANCE IN HEMATOPOIETIC STEM CELL AGING AND LEUKEMIC PROGRESSION

EHA Library, Sho Shibata, 4159258

POISONING OF HEMATOPOIESIS DRIVES CLONAL DOMINANCE AND BONE MARROW FAILURE IN VEXAS SYNDROME

EHA Library, Martina Fiumara, 4159257

CHARACTERIZATION & EFFICACY OF TERN-701 IN PRE-CLINICAL MODELS OF CHRONIC MYELOID LEUKEMIA

EHA Library, Ben Parsons, 4159246

COMPARISON OF MOLECULAR RESPONSE AND SAFETY OF LOWER DOSE (70 MG) VERSUS STANDARD DOSE (100 MG) OF GENERIC DASATINIB IN NEWLY DIAGNOSED PATIENTS WITH CML-CP: RANDOMISED CONTROLLED STUDY FROM INDIA

EHA Library, Paras Satadeve, 4159245

CHRONIC MYELOID LEUKEMIA (CML) TREATMENT DISCONTINUATION AFTER A TWO-STEP DOSE REDUCTION. THE FIRST RESULTS OF THE PHASE 2 STUDY HALF.

EHA Library, Jiří Mayer, 4159244

ASCIMINIB (ASC) SHOWS SUPERIOR TOLERABILITY VS NILOTINIB (NIL) IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): PRIMARY ENDPOINT RESULTS OF THE PHASE (PH) 3B ASC4START TRIAL

EHA Library, Andreas Hochhaus, 4159243

ENABLE: A PHASE 1A/1B STUDY OF ELVN-001, A SELECTIVE ACTIVE SITE INHIBITOR OF BCR::ABL1, IN PATIENTS WITH PREVIOUSLY TREATED CML

EHA Library, Andreas Hochhaus, 4159242

PENTOSE PHOSPHATE PATHWAY REGULATED THROUGH IL-21 CONTROLS TUMOR PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Anna Kabanova, 4159230

UNVEILING RYK: A BREAKTHROUGH TUMOR-ASSOCIATED ANTIGEN IN LYMPHOMA TREATMENT

EHA Library, Matilde Micillo, 4159229

CHRONIC LYMPHOCYTIC LEUKEMIA CELLS RELY ON GLUTAMINE: IMPLICATIONS FOR THERAPY AND DIAGNOSTICS

EHA Library, Helga Simon-Molas, 4159228

CLL-LIKE EPIGENETIC AND TRANSCRIPTOMIC STATES ARE PRESENT IN LOW-COUNT MBL AS REVEALED BY SINGLE-CELL MULTI-OMICS ANALYSES

EHA Library, Anja Rathgeber, 4159227

FIRST-IN-HUMAN STUDY OF ASCIMINIB (ASC) MONOTHERAPY IN ADULTS WITH RELAPSED/REFRACTORY (R/R) PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL)

EHA Library, Michael Mauro, 4159196

LONG-TERM FOLLOW-UP OF AN INTENSIVE PEDIATRIC REGMEN FOR ADOLESCENTS/YOUNG ADULTS (AYA) WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): 10-YEAR SURVIVAL FOLLOWING CALGB 10403 (ALLIANCE)

EHA Library, Wendy Stock, 4159195

SAFETY AND EFFICACY OF AZD0486 IN ADOLESCENT AND ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: EARLY RESULTS FROM THE PHASE 1/2 SYRUS STUDY

EHA Library, Ibrahim Aldoss, 4159194

ACHIEVEMENT OF MRD NEGATIVITY AFTER END OF INDUCTION WITH PONATINIB AND IMATINIB IN THE PHASE 3 PHALLCON TRIAL: A POST HOC ANALYSIS

EHA Library, Carlo Gambacorti-Passerini, 4159193

ADVANCING CHEMOGENOMIC STRATEGIES FOR FUNCTIONAL PRECISION MEDICINE IN RELAPSED/REFRACTORY T-ALL AND ETP-ALL: PRELIMINARY RESULTS OF THE GIMEMA ALL2720 TRIAL

EHA Library, Luca Pagliaro, 4159192